+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Protein Expression Market Report and Forecast 2024-2032

  • PDF Icon


  • 140 Pages
  • May 2024
  • Region: Global
  • Expert Market Research
  • ID: 5973995
The global protein expression market size was valued at USD 3 billion in 2023, driven by advancements in CRISPR technology globally. The market is expected to grow at a CAGR of 5.40% during the forecast period of 2024-2032, with the values likely to rise from USD 3.2 billion in 2024 to USD 4.9 billion by 2032.

Global Protein Expression Market Analysis

The global protein expression market has seen substantial evolution from 2017 to 2032, influenced by a convergence of scientific advancements, expanding demands in biotechnology and pharmaceutical research, and the growing need for therapeutic protein production. These elements have been pivotal in shaping market dynamics, fostering innovation, and expanding the application range of protein expression technologies. The following are the key trends and developments observed in this market over the specified period.

Global Protein Expression Market Trends

The global protein expression market from 2017 to 2032 has been marked by several significant trends that reflect the evolving landscape of biotechnology, pharmaceuticals, and academic research. These trends highlight the dynamic nature of the market, driven by technological advancements, growing demand across various applications, and strategic shifts in global healthcare and biopharmaceutical industries. Below are the key market trends observed during this period:

Technological Advancements in Expression Systems: One of the most significant trends is the rapid advancement in protein expression technologies. Innovations have spanned across different expression systems, including bacterial, yeast, mammalian, and insect cells, with each system being optimized for higher yields, better protein quality, and greater cost-effectiveness. These technological improvements have enabled more efficient production of recombinant proteins, antibodies, vaccines, and therapeutics, catering to the increasing demands of research and development in life sciences.

  • Rising Demand for Therapeutic Proteins: The protein expression market has been significantly impacted by the soaring demand for therapeutic proteins. This is largely due to the global increase in the prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, which has spurred the need for biologics, including monoclonal antibodies, hormones, and enzymes. The push towards personalized medicine has further amplified this demand, positioning protein expression as a critical component in the development and manufacturing of biopharmaceuticals.
  • Expansion into Emerging Markets: The period has also seen the protein expression market expand its footprint into emerging markets, especially in Asia-Pacific and Latin America. These regions have witnessed rapid growth due to improvements in healthcare infrastructure, increased investments in biotechnology, and supportive government policies. The expanding research and development activities, coupled with a growing biopharmaceutical sector in these regions, have opened new avenues for market growth.
  • Integration of Synthetic Biology and CRISPR Technologies: The integration of synthetic biology and CRISPR/Cas9 gene-editing technologies into protein expression practices have emerged as a transformative trend. These technologies have facilitated the development of novel protein variants, optimized expression vectors, and customized cell lines, thereby broadening the applications of protein expression in research, therapeutics, and industrial biotechnology.
  • Focus on High-throughput and Automated Systems: With the increasing complexity and scale of protein production, there has been a marked shift towards high-throughput and automated protein expression systems. These systems offer enhanced efficiency, scalability, and reproducibility, meeting the needs of large-scale protein production for therapeutic and industrial applications. Automation has also played a crucial role in streamlining workflows, reducing labor costs, and improving overall productivity in protein expression operations.
  • Regulatory and Quality Assurance Considerations: The regulatory landscape for biopharmaceutical products has become increasingly stringent, impacting the protein expression market. Compliance with Good Manufacturing Practices (GMP), regulatory approvals, and quality assurance standards have become paramount, especially for therapeutic protein production. This trend has necessitated the adoption of advanced expression systems and purification technologies that ensure high-quality protein products, suitable for clinical and commercial use.
  • Custom and Contract Expression Services: The growth of custom and contract protein expression services represents another key trend, driven by the specialized needs of pharmaceutical and biotech companies, as well as academic institutions. Outsourcing protein expression projects to specialized service providers has allowed organizations to leverage expert knowledge, advanced technologies, and cost-effective solutions without significant in-house investments, fostering collaborations and accelerating the pace of research and development.

Global Protein Expression Market Segmentation

Market Breakup by Type of Expression System

  • Bacterial Expression Systems
  • Mammalian Expression Systems
  • Yeast Expression Systems
  • Insect Expression Systems
  • Cell-Free Expression Systems
  • Algal Expression Systems
  • Other Expression Systems
The global protein expression market is segmented based on the type of expression system used, each catering to specific requirements and applications. Bacterial expression systems are widely utilized for their simplicity and high yield, making them ideal for basic research and industrial applications. Mammalian expression systems are preferred for producing proteins with complex post-translational modifications. Yeast expression systems offer a balance between ease of use and the ability to perform eukaryotic post-translational modifications. Insect expression systems are used for high yield protein production, especially for vaccines and therapeutic proteins. Cell-free expression systems provide a versatile platform for rapid protein synthesis without the need for living cells, facilitating high-throughput applications. Algal expression systems are emerging as a cost-effective and environmentally friendly alternative for producing recombinant proteins. Other expression systems include a variety of novel platforms designed to meet specific research and production needs, expanding the possibilities in protein expression technologies.

Market Breakup by Product Type

  • Reagents
  • Expression Vectors
  • Competent Cells
  • Instruments
  • Services
The global protein expression market is diverse, with several key segments catering to the varied needs of researchers and biotechnologists. Reagents, essential for initiating and sustaining protein synthesis, form a foundational segment, offering a wide range of biochemicals necessary for efficient protein production. Expression vectors are pivotal, providing the genetic blueprints that guide the synthesis of proteins of interest. Competent cells, genetically engineered to enhance DNA uptake, play a crucial role in ensuring high-efficiency protein expression. Instruments, including sophisticated machinery for synthesizing, maintaining, and analyzing proteins, are indispensable for modern laboratories aiming for precision and scalability. Services, offering expert support ranging from vector construction to protein purification, cater to those requiring specialized knowledge or equipment, thus facilitating seamless protein expression projects. Each segment collectively underpins the robust growth and innovation within the global protein expression market.

Market Breakup by Application

  • Therapeutic Proteins
  • Research Applications
  • Industrial Proteins
  • Diagnostic Proteins
  • Others
The global protein expression market is diversified into several key segments, each catering to unique needs and advancements in biotechnology. Therapeutic proteins lead innovative treatments for chronic diseases, leveraging biologics to offer targeted and effective solutions. Research applications follow, where protein expression is critical in understanding disease mechanisms and developing new drugs. Industrial proteins emphasize scalability, serving sectors like agriculture and biofuels with enzymes and other protein-based products. Diagnostic proteins are pivotal in advancing personalized medicine, providing precise biomarkers for disease identification and management. Lastly, the "Others" segment encompasses emerging applications, including cosmetic and nutritional proteins, showcasing the versatile potential of protein expression technology across various industries.

Market Breakup by Technique

  • Ion Exchange Chromatography
  • Hydrophobic Interaction Chromatography (HIC)
  • Affinity Chromatography
  • Size Exclusion Chromatography
  • Others
The global protein expression market is categorized into several techniques, each serving specific needs. Ion Exchange Chromatography is highly efficient for protein purification, leveraging charge-charge interactions. Hydrophobic Interaction Chromatography (HIC) isolates proteins based on their hydrophobicity, making it indispensable for purifying membrane proteins. Affinity chromatography stands out for its specificity, using ligand-protein interactions, ideal for high-purity applications. Size Exclusion Chromatography separates proteins based on molecular size, crucial for analyzing protein aggregates. Other techniques, including novel and hybrid methods, cater to niche applications, ensuring comprehensive coverage across research and industrial landscapes.

Market Breakup by Cell Type

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Insect Cells
  • Algal Cells
  • Cell-Free Systems
The global protein expression market is diverse, encompassing various cell types each tailored for specific applications. Mammalian cells are favored for their post-translational modifications, closely mirroring human proteins, ideal for therapeutic use. Bacterial cells offer simplicity and high yield, making them suitable for basic research and industrial applications. Yeast cells strike a balance with relatively quick growth and the ability to perform eukaryotic post-translational modifications. Insect cells are utilized for their complex protein processing capabilities, often used in vaccine production. Algal cells present a sustainable option, requiring less resources and producing minimal waste. Lastly, cell-free systems offer a versatile platform for rapid protein synthesis without the limitations of cell-based systems, facilitating high-throughput screening and prototyping. Each segment caters to specific needs, driving advancements in biotechnology and medical research.

Market Breakup by End User

  • Biotechnology and Pharmaceutical Companies
  • Academic Research Institutes
  • Contract Research Organizations (CROs)
  • Others
The global protein expression market caters to a diverse range of end-users, each with specific demands and applications. Biotechnology and pharmaceutical companies lead, utilizing advanced protein expression technologies for drug discovery and therapeutic protein production. Academic research institutes follow closely, employing these techniques for groundbreaking scientific studies and educational purposes. Contract Research Organizations (CROs) leverage protein expression services to provide outsourced research support, benefiting from the scalability and expertise offered. Lastly, other segments, including governmental and non-profit research entities, utilize these technologies for various research and development activities, further expanding the market's reach and impact.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
The global protein expression market is divided into several key regions, each contributing uniquely. North America leads with advanced biotechnology infrastructures and robust research activities. Europe follows, with its strong emphasis on pharmaceutical and academic research driving demand. The Asia Pacific region is rapidly growing, fueled by expanding biotech industries and increasing investments in healthcare. Latin America, though smaller, is showing promising growth due to evolving biotech capabilities. Lastly, the Middle East and Africa are emerging markets, benefiting from growing biopharmaceutical interest and research investments, poised for future expansion.

Global Protein Expression Market Competitive Landscape

The global protein expression market is highly competitive and fragmented, with the presence of several major players and numerous smaller ones. Key players involved in the market are Thermo Fisher Scientific, Inc., Merck KGaA (Sigma-Aldrich Corporation), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Lonza Group AG, Genscript Biotech Corporation, Takara Bio Inc., Promega Corporation, New England Biolabs, Oxford Expression Technologies Ltd. (OET), Synthetic Genomics, Inc., Biomatik Corporation, Cayman Chemical Company, and Zymo Research Corporation. These companies compete on various factors, such as product quality, innovation, pricing, customer service, distribution network, and geographical reach. They also engage in strategic partnerships, mergers and acquisitions, product launches, and expansion activities to strengthen their market position and expand their product portfolio.

Key Questions Answered in This Report

  • How has the protein expression market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the protein expression market?
  • What is the impact of each driver, restraint, and opportunity in the market?
  • What are the key regional markets?
  • Which major technological advancement has increased the potential of protein expression systems in synthetic biology?
  • Which countries represent the most attractive market?
  • What are market segmentations based on cell type?
  • What is the breakup of the market based on the diagnosis?
  • What is the competitive structure of the market?
  • Who are the major players/companies dominating the market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the protein expression from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global protein expression market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the protein expression industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Protein Expression Market Overview
3.1 Global Protein Expression Market Historical Value (2017-2023)
3.2 Global Protein Expression Market Forecast Value (2024-2032)
4 Global Protein Expression Market Landscape*
4.1 Global Protein Expression: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Protein Expression: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Application
5 Global Protein Expression Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Protein Expression Market Segmentation (2017-2032)
6.1 Global Protein Expression Market (2017-2032) by Type of Expression System
6.1.1 Market Overview
6.1.2 Bacterial Expression Systems
6.1.3 Mammalian Expression Systems
6.1.4 Yeast Expression Systems
6.1.5 Insect Expression Systems
6.1.6 Cell-Free Expression Systems
6.1.7 Algal Expression Systems
6.1.8 Other Expression Systems
6.2 Global Protein Expression Market (2017-2032) by Product Type
6.2.1 Market Overview
6.2.2 Reagents
6.2.3 Expression Vectors
6.2.4 Competent Cells
6.2.5 Instruments
6.2.6 Services
6.3 Global Protein Expression Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Therapeutic Proteins
6.3.3 Research Applications
6.3.4 Industrial Proteins
6.3.5 Diagnostic Proteins
6.3.6 Others
6.4 Global Protein Expression Market (2017-2032) by Technique
6.4.1 Market Overview
6.4.2 Ion Exchange Chromatography
6.4.3 Hydrophobic Interaction Chromatography (HIC)
6.4.4 Affinity Chromatography
6.4.5 Size Exclusion Chromatography
6.4.6 Others
6.5 Global Protein Expression Market (2017-2032) by Cell Type
6.5.1 Market Overview
6.5.2 Mammalian Cells
6.5.3 Bacterial Cells
6.5.4 Yeast Cells
6.5.5 Insect Cells
6.5.6 Algal Cells
6.5.7 Cell-Free Systems
6.6 Global Protein Expression Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Biotechnology and Pharmaceutical Companies
6.6.3 Academic Research Institutes
6.6.4 Contract Research Organizations (CROs)
6.6.5 Others
6.7 Global Protein Expression Market (2017-2032) by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Protein Expression Market (2017-2032)
7.1 North America Protein Expression Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Reagents
7.1.3 Expression Vectors
7.1.4 Competent Cells
7.1.5 Instruments
7.1.6 Services
7.2 North America Protein Expression Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Therapeutic Proteins
7.2.3 Research Applications
7.2.4 Industrial Proteins
7.2.5 Diagnostic Proteins
7.2.6 Others
7.3 North America Protein Expression Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Protein Expression Market (2017-2032)
8.1 Europe Protein Expression Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Reagents
8.1.3 Expression Vectors
8.1.4 Competent Cells
8.1.5 Instruments
8.1.6 Services
8.2 Europe Protein Expression Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Therapeutic Proteins
8.2.3 Research Applications
8.2.4 Industrial Proteins
8.2.5 Diagnostic Proteins
8.2.6 Others
8.3 Europe Protein Expression Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Protein Expression Market (2017-2032)
9.1 Asia Pacific Protein Expression Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Reagents
9.1.3 Expression Vectors
9.1.4 Competent Cells
9.1.5 Instruments
9.1.6 Services
9.2 Asia Pacific Protein Expression Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Therapeutic Proteins
9.2.3 Research Applications
9.2.4 Industrial Proteins
9.2.5 Diagnostic Proteins
9.2.6 Others
9.3 Asia Pacific Protein Expression Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Protein Expression Market (2017-2032)
10.1 Latin America Protein Expression Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Reagents
10.1.3 Expression Vectors
10.1.4 Competent Cells
10.1.5 Instruments
10.1.6 Services
10.2 Latin America Protein Expression Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Therapeutic Proteins
10.2.3 Research Applications
10.2.4 Industrial Proteins
10.2.5 Diagnostic Proteins
10.2.6 Others
10.3 Latin America Protein Expression Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Protein Expression Market (2017-2032)
11.1 Middle East and Africa Protein Expression Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Reagents
11.1.3 Expression Vectors
11.1.4 Competent Cells
11.1.5 Instruments
11.1.6 Services
11.2 Middle East and Africa Protein Expression Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Therapeutic Proteins
11.2.3 Research Applications
11.2.4 Industrial Proteins
11.2.5 Diagnostic Proteins
11.2.6 Others
11.3 Middle East and Africa Protein Expression Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Thermo Fisher Scientific, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Merck KGaA (Sigma-Aldrich Corporation)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Agilent Technologies, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Bio-Rad Laboratories, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 QIAGEN N.V.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Lonza Group AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Genscript Biotech Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Takara Bio Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Promega Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 New England Biolabs
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Oxford Expression Technologies Ltd. (OET)
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Synthetic Genomics, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Biomatik Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Cayman Chemical Company
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Zymo Research Corporation
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Protein Expression Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The research team strives to make this section as comprehensive as possible.

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA (Sigma-Aldrich Corporation)
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Lonza Group AG
  • Genscript Biotech Corporation
  • Takara Bio Inc.
  • Promega Corporation
  • New England Biolabs
  • Oxford Expression Technologies Ltd. (OET)
  • Synthetic Genomics Inc.
  • Biomatik Corporation
  • Cayman Chemical Company
  • Zymo Research Corporation



Table Information